CT-P44
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CT-P44, covering 2025-08-15 to 2025-08-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma [Phase 3]